Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations

RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures

(2014) Francianne Gomes Andrade et al.   BMC CANCER

Gender Difference in Systemic Oxidative Stress and Antioxidant Capacity in Current and Former Heavy Smokers

(2012) I. A. Hakim et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

KRAS Mutations in Lung Cancer

(2012) Niki Karachaliou et al.   Clinical Lung Cancer

EGFRexon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients

(2012) Shi-Yi Yang et al.   INTERNATIONAL JOURNAL OF CANCER

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells

(2012) David Siegel et al.   PLoS One

Sp1 Upregulates Survivin Expression in Adenocarcinoma of Lung Cell Line A549

(2011) Yuqing Chen et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

(2011) N. Sunaga et al.   MOLECULAR CANCER THERAPEUTICS

Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway

(2011) Hyun-Jung An et al.   MOLECULES AND CELLS

Co-Activation of Epidermal Growth Factor Receptor and c-MET Defines a Distinct Subset of Lung Adenocarcinomas

(2010) Daisuke Matsubara et al.   AMERICAN JOURNAL OF PATHOLOGY

Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation

(2010) Jiru Chu et al.   CANCER LETTERS

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy

(2010) Stephen J. Ralph et al.   MOLECULAR ASPECTS OF MEDICINE

Increased mitochondrial DNA damage and decreased base excision repair in the auditory cortex of d-galactose-induced aging rats

(2010) Bei Chen et al.   MOLECULAR BIOLOGY REPORTS

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

(2010) F. Weinberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer

(2009) Si Yeol Song et al.   LUNG CANCER

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Oxidative stress, DNA methylation and carcinogenesis

(2008) Rodrigo Franco et al.   CANCER LETTERS

Disruption of NAD(P)H:Quinone Oxidoreductase 1 Gene in Mice Leads to Radiation-Induced Myeloproliferative Disease

(2008) K. Iskander et al.   CANCER RESEARCH

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras

(2008) Y. Yang et al.   MOLECULAR CANCER THERAPEUTICS